In PDC/PDCX models, we showed that NRN1 promotes in vitro and in vivo RCC proliferation, and NRN1 silencing downregulates CXCR4, a gene co-expressed with NRN1, that is also a prognostic and CSC marker in RCC. Here, NRN1 is linked to renal cell carcinoma.